Constitution and Steering Group
On 13 December 2016 the University announced the formation of seven Specialist Research Institutes (SRIs) following a competitive application process. Under the University’s new strategy plan, an SRI represents a field in which Bristol is acknowledged to be a world leader and where there is significant alignment with regional, national and international ambitions. The SRI will complement existing disciplinary strengths in Schools and Faculties and will be sufficiently limited in number to have an effective role in institutional branding.
The seven Institutes include:
- Bristol BioDesign Institute (Dir: Dek Woolfson)
- Bristol Heart Institute (Dir: Gianni Angelini)
- Bristol Composites Institute (Dir: Michael Wisnom)
- Bristol Migration and Mobility Institute (Dirs: Chris Bertram & Julia O'Connell Davidson)
- Bristol Population Health Science Institute (Dir: Caroline Relton)
- Bristol Poverty Institute (Dir: Dave Gordon)
- Bristol Quantum Information Institute (Dir: Noah Linden)
An external launch of the SRIs is anticipated in March 2017.
From 2017 University Research Themes will cease to be formally endorsed and presented at an institutional level. This means that BCV will cease to function in its current state and will be absorbed into the newly formed Bristol Heart Institute. The BCV steering group met for the last time on 14 December 2016.
Meetings are taking place with various stakeholders across the University to finalise the terms of reference for the SRIs and ensure that appropriate support is in place. Changes will therefore be taking place, but every effort will be made to ensure the transition from BCV to an SRI is as smooth as possible. To ease the process it was agreed on 23 February 2017 that the interim SRI steering group will comprise the former members of the BCV steering group. The Director, Prof Gianni Angelini, will be supported by Prof Alastair Poole as Deputy Director (who is also FRD for Biomedical Sciences).
In the coming weeks and months, therefore, some metamorphosis will occur but this should not adversely affect the cardiovascular community in any way.
BCV has played a significant role in bringing the research community together from across the University and the Bristol Royal Infirmary, and as such we are justly proud of recent achievements, including a successful British Heart Foundation (BHF) PhD Programme, BHF Chair renewals, and the Medical Research Council Biomedical Research Centre award.
We very much look forward to highlighting the many successful activities of the community to a wider audience, and forging on to the next level in terms of cardiovascular cohesion and strategy in the coming years.
Bristol Heart Institute Steering Group
The committee currently consists of:
- Professor Gianni Angelini Director: Cardiac surgery
- Professor Alastair Poole Deputy Director: Platelet cell biology
- Dr Chiara Bucciarelli-Ducci Imaging
- Professor Massimo Caputo Congenital Heart Surgery
- Professor Costanza Emanueli Cardiovascular Regeneration
- Professor Sarah George Cardiovascular Signalling
- Dr Emma Hart Autonomic Regulation & Dysfunction
- Dr Andrew James Cardiac Biology
- Dr Thomas Johnson Cardiology
- Dr Stuart Mundell Vascular Biology and atherothrombosis
- Professor Ruth Newbury-Ecob Clinical Genetics
- Dr Simon Satchell Renal, Diabetic & Hypertensive Disease
- Professor Saadeh Suleiman Biomedical Research Unit
- Dr Nicholas Timpson Population Health and Epidemiology
- Professor Robert Tulloh Congenital Heart Disease
- Collette Sheahan RED liaison